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Abstract The distressed personality type (“type D person-
ality”) has been shown to be associated with low quality of
life and higher morbidity and mortality in various patient
groups. Because the role of type D personality is unknown
in patients with rheumatoid arthritis (RA), the aim of the
present study was to investigate the association of type D
personality with aspects of quality of life and disease activ-
ity in RA patients. In addition, a potential buffering effect by
accepting mindfulness was examined. Participants were 147
patients between 22 and 87 years of age. Patients completed
relevant questionnaires at home and the disease activity
score was determined. After controlling for potentially con-
founding variables, multivariate analyses of covariance
showed an association of type D personality with a lower
satisfaction with life (p<0.001) and a lower psychological
well-being (p<0.001), but not disease activity in RA
patients. Although mindfulness was associated with a higher
satisfaction with life (p00.02) and positive mood (p00.01),
it did not diminish the unfavourable associations between
type D and well-being. In conclusion, although type D
personality is related with lower well-being, it does not
seem to be associated with disability or disease activity in
RA patients.
Keywords Disease activity.Distressed(typeD)
personality.Mindfulness.Qualityoflife.Rheumatoid
arthritis.Well-being
Introduction
Rheumatoid arthritis (RA) is the most common chronic
autoimmune arthritis [1, 2]. The disease generally follows
ar e m i t t i n g –flaring course of inflammation and pain and
leads to increasing functional disability [1, 2]. Patients con-
fronted with the diagnosis of RA have to change their way
of living [3] and they experience psychological distress
more often than people in the general population [4]. The
disease requires adaptation and involves many future uncer-
tainties because it cannot be cured. Therefore quality of life
in this population is recognised as a very important treat-
ment outcome [5]. The evaluation of this quality depends
not only on the disease activity. Individuals can vary greatly
in their psychological adaptation to the disease and this is
not always explained by variations in inflammatory activity
[6]. Patients with a comparable clinical picture and time
since their diagnosis can evaluate their quality of life quite
differently. This means that other factors than only the
medical parameters may be responsible for these differen-
ces. An emerging area of explanation of individual differ-
ences in quality of life and physical functioning in medical
patients in general involve relatively stable individual dis-
positions such as personality [7].
There is only little research regarding the relation be-
tween personality and the individual differences in quality
of life and physical functioning in rheumatoid arthritis
patients. Optimism and the tendency to hold greater positive
outcome expectancies have been found to be related to
better psychological well-being in RA patients [8].
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well, optimistic patients report fewer symptoms [9]. Patients
with negative affectivity (the tendency to experience nega-
tive mood states across situations and one of the compo-
nents of type D personality, see below) are reported to show
lower health satisfaction scores [10]. RA patients in general
report higher levels of negative affectivity compared to the
general population [3, 11]. Negative affectivity is associated
with more negative emotions, including more symptoms of
anxiety and depression, which are known to affect quality of
life unfavourably [12].
Psychological characteristics have been found to be im-
portant determinants of functioning in other chronic dis-
eases. The distressed personality type (type D personality)
has been identified as an important explanatory factor of
individual differences in quality of life and also clinical
outcomes in various patient groups, ranging from chronic
pain patients to patients with malignant melanoma [13].
Type D personality refers to patients who frequently expe-
rience negative emotions across situations (are high in neg-
ative affectivity) in combination with a tendency not to
express affect to others (termed social inhibition) [7, 14,
15]. Most type D personality research has been performed
in patients with cardiovascular diseases [7, 16], in which
patients with a type D personality have been found not only
to have an increased risk of psychological distress, but also
adverse clinical health status [7, 14, 17] and impaired qual-
ity of life [18]. Type D personality is also associated with a
high risk of cardiac events, such as myocardial infarction
[15, 19] and a threefold increased risk of a cardiac death in
cardiac patients [14, 17]. In addition, type D personality has
been found to be associated with enhanced levels of pro-
inflammatory cytokines TNF-α and its receptors [20],
which are important disease parameters in RA [21].
While the role of type D personality in cardiac and some
other somatic patients has been found, the role of this
psychological characteristic in rheumatoid arthritis patients
is unknown. Given its relations with psychological well-
being, quality of life and levels of pro-inflammatory cyto-
kines in other patient samples, type D personality may be an
important factor in rheumatoid patients as well.
In addition, mindfulness may be hypothesised to be a
buffering factor concerning the negative consequences of
type D personality on aspects of quality of life and perhaps
even physical health status. Mindfulness is commonly de-
fined as the state of being attentive to and aware of what is
taking place in the present with an open and accepting (non-
judgemental) attitude. This quality of attention to the present
moment has been claimed to buffer adverse consequences of
negative emotions, which are strongly present in type Ds, by
(a) identification and letting go of ruminative thoughts about
the past or future and (b) mental and bodily relaxation [22].
Indeed, mindfulness-based psychological interventions have
been reported to enhance quality of life [23–25] and de-
crease pain or coping with pain [26, 27] in various clinical
and non-clinical samples. In addition, preliminary data sug-
gest that mindfulness is associated with psychological well-
being in fibromyalgia patients [28] and that mindfulness-
based interventions may decrease T cell production of pro-
inflammatory cytokines [29] which may be beneficial in RA
patients.
Therefore, the aim of the study was to investigate the
association of the distressed personality type (type D per-
sonality) with aspects of quality of life, including psycho-
logical well-being, life satisfaction and disability, as well as
disease activity in rheumatoid arthritis patients and the po-
tentially buffering effect of mindfulness. The hypotheses are
that (a) type D patients report lower levels of these aspects
of quality of life compared with non-type D patients, while
(b) they show a more severe disease activity; (c) mindful-
ness buffers the effects mentioned in hypotheses (a) and (b).
Method
Patients and procedure
Participants were recruited in the Regional Rheumatic Center
ZO-Brabant, Eindhoven, the Netherlands, and were provided
with information about the study by the rheumatologist. The
study complied with the Helsinki Declaration on human sub-
jects; the protocol being approved by the Medical Ethics
Committee of the Máxima Medical Center, Eindhoven, the
Netherlands.
Inclusion criteria were a diagnosis of rheumatoid arthri-
tis, starting treatment with methotrexate or a TNF-α antag-
onist (for a substudy not reported on here) and sufficient
understanding of written and spoken Dutch language. All
patients had to be included within 4 weeks after start with
this medication. The exclusion criteria were age ≥90 years,
chronic severe psychiatric conditions (e.g. psychosis or a
personality disorder) and any infections during last week. If
the latter condition was the case, but was very temporary
(such as common cold), we aimed to postpone the inclusion
by 1 or 2 weeks, depending on the duration of the condition.
After explanation of the study, patients were asked to
complete a questionnaire at home and to send it back within
1 week. In the case of refusal, a short questionnaire with
general variables such as gender, age, marital status, level of
education and the time since diagnosis was attached to be
able to compare participants with nonparticipants. Data
were collected from 162 individuals: 147 participants
(91%) who completed questionnaires and 15 nonpartici-
pants (9%). None of the patients refused to provide the
general data.
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tologist and had to be determined within a month before and
a month after the questionnaire was completed. Average
time between patients' completion of the questionnaire and
measurement of disease activity score was 5.6±9.6 days.
Materials
Questionnaires
Type D personality was measured using the 14-item type
D Scale (DS14) [15]. This questionnaire consists of
two subscales, negative affectivity and social inhibition, of
seven items each. Items are scored on a five-point Likert
scale ranging from 0 (false) to 4 (true). A cutoff score of ≥10
on both scales is conventionally used to classify subjects as
having type D personality. In previous research on the Dutch
version, the test–retest reliability over a 3-month period was
0.72 and 0.82 for negative affectivity and social inhibition,
respectively, and the internal consistency (Cronbach's α)
was 0.88 and 0.86, respectively. Evidence for construct
validity is also provided [15]. In this sample, the internal
consistency was 0.83 for both subscales.
Mindfulness was assessed by means of the Freiburg
Mindfulness Inventory-short-form (FMI-s) [30]. The FMI-
s consists of 14 items and is regarded as an index of overall
mindfulness, including the aspects of attention to external
and internal (proprioceptive and psychological) phenomena
in the present moment, accepting self-reflection and a non-
reacting stance. These items are scored on a four-point
Likert scale ranging from 1 (rarely) to 4 (almost always).
The original FMI-s has shown good construct validity and
internal consistency (Cronbach's α of 0.86) [30]. Because
no Dutch translation was available at the start of the study,
the second author (IN) translated the FMI-s into Dutch
together with Drs. M. van der Lee and C. Völker (Helen
Dowling Institute, the Netherlands) and Dr. M. Schroevers
(Groningen University, Netherlands), one of which is a
native German speaker, using the standard back-translation
method. Because of this new translation, we carefully tested
the internal consistency in the present sample, resulting in a
satisfactory Cronbach's α of 0.79.
Various instruments were used to measure different
aspects of quality of life. The Health Assessment Question-
naire [31] has been validated in groups of patients with a
wide variety of rheumatic diseases, including rheumatoid
arthritis, and measures the degree of disability. We used the
standard Dutch version [32], which consists of 20 items in
eight categories which represent a comprehensive set of
functional activities (dressing and grooming, arising, eating,
walking, hygiene, reach, grip and common daily activities).
These questions are part of the disability index score, with-
out including questions regarding aids and devices and ask
about the past week: “Are you able to…” perform a partic-
ular task. The responses are scored on a four-point Likert
scale ranging from 0 (without any difficulty) to 3 (unable to
do) [31]. The Dutch version has good reliability: Cronbach's
α was between 0.85 and 0.95 in previous research [32] and
0.89 in this sample.
The Dutch version of the Satisfaction with Life Scale
[33] is a brief questionnaire consisting of five items using
a seven-point Likert scale ranging from 1 (strongly disagree)
to 7 (strongly agree). It measures how satisfied patients are
with their present life. This questionnaire has an adequate
construct validity and internal consistency: Cronbach's α of
0.87 in previous research [33] and 0.92 in this study.
The Dutch Global Mood Scale [34] consists of ten pos-
itive and ten negative mood terms. The patients have to
answer on a five-point Likert scale ranging from 0 (not at
all) to 4 (extremely), the extent to which they have experi-
enced each mood state lately. This questionnaire has ade-
quate construct validity and good internal consistency
(Cronbach's α of 0.90 in previous research) [34] and Cron-
bach's α of 0.93 and 0.88 for negative and positive affect,
respectively in this study.
The Dutch Symptoms of Anxiety and Depression [35]
scale consists of four items which are scored on a five-point
Likert scale ranging from 0 (not at all) to 4 (very much). The
questionnaire is a reliable and brief index of mixed anxiety–
depression symptoms. In this sample the Cronbach's α was
0.85. Also in previous research, the scale had good internal
consistency (Cronbach's α of 0.86) and validity [35].
Finally a questionnaire was employed for assessing differ-
ent sociodemographic control variables, such as age, gender,
education level (low0lower than midlevel vocational educa-
tion; high is at least midlevel vocational education) and mar-
ital status (having a partner or not). The medical control
variables time since diagnosis and treatment (methotrexate
or a TNF-α antagonist) were obtained from medical records.
Disease activity score
The Disease Activity Score (DAS-28) [2] is originally a
Dutch instrument that indicates how active the RA is at a
certain moment. The DAS-28 consists of four parts: (a) the
amount of swollen joints and (b) the amount of tender joints
as determined by the rheumatologist, (c) a general health
assessment on a visual analogue scale (VAS) (from 1–100)
obtained from the patient on self-evaluated disease severity
and (d) erythrocyte sedimentation in the blood. The DAS-28
score can be calculated using the formula; DAS-2800.54(√
number of tender joints)+0.065 (number of swollen joints)+
0.33 (Ln erythrocyte sedimentation)+0.0072 (VAS score).
This total score is a number between 0 and 10, indicating the
amount of disease severity. This composite measure has
shown adequate validity [2, 36].
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All analyses were performed using SPSS software. First
participants and nonparticipants were compared on age,
gender, education, marital status and time since diagnosis
using independent sample t tests or chi-square tests.
The main analyses were multivariate analyses of covari-
ance (MANCOVA) to examine associations between type D
personality (independent variable) and the outcome varia-
bles. Separate analyses were performed for the cluster of
psychological variables (negative affect, positive affect,
symptoms of anxiety and depression, health status and sat-
isfaction with life) and for the cluster of disease activity
variables (swollen joints, tender joints, level of erythrocyte
sedimentation and VAS). In addition, the association be-
tween type D, mindfulness and total DAS-28 was examined
using a separate univariate analysis of covariance. Finally,
the type D by mindfulness interaction was explored on all
outcome variables to examine the potential buffer effect by
mindfulness. An α level of 0.05 was used in all analyses. In
addition, all analyses were controlled for age, gender, edu-
cation level, time since diagnosis and treatment condition
(methotrexate versus TNF-α).
Results
Participants had a higher educational level than individuals
who did not participate in the study: 87 (59.6%) versus 3
(20.0 %) patients had at least midlevel vocational education
(χ
2 [1]07.12, p00.008). The nonparticipants did not differ
from participants (all p>0.10) regarding age (57.4±11.3 vs
57.2±10.7 years), gender (81 (55.1%) vs 10 (66.7%) wom-
en), marital status (117 (80.1%) vs 11 (73.3%) having a
partner), treatment (116 (78.9%) vs 10 (66.7%) having
methotrexate) or time since diagnosis (51.6±101.6 vs 42.4±
54.7 months).
Due to occasional missing data on the questionnaire data,
analyses on questionnaire data were based on 141 patients,
of whom 43 (30.5%) had a type D personality and 98
(69.5%) were not type Ds, which is comparable to previous
findings in cardiac patients [15]. Patients with a type D
personality did not differ from non-type Ds regarding
all sociodemographic and background medical variables
(Table 1). Type D patients did score lower on mindfulness
compared with non-type D patients (35.0±5.7 vs 38.4±6.5; t
[139]02.94, p00.004).
Aspects of quality of life
Several covariates showed significant associations with
some aspects of quality of life. Age was negatively associ-
ated with negative affect (F [1,124]06.56, p00.01;
unstandardized β coefficient0−0.20, η
200.05), positively
with life satisfaction (F [1,124]06.33, p00.01, unstandard-
ized β00.15, η
200.05), but also positively with disability
ratings (F [1,124]04.09, p00.05, unstandardized β00.01,
η
200.03). Women reported a higher disability than men (F
[1,124]05.99, p00.02, η
200.05) and reported more symp-
toms of anxiety and depression (F [1,124]08.66, p00.01,
η
200.07). Longer time since diagnosis was associated with
higher disability scores (F [1, 124]06.67, p00.01, unstan-
dardized β00.002, η
200.05), but fewer symptoms of anxiety
and depression (F [1,124]04.19, p00.04, unstandardized
β0−0.01, η
200.03). There were no significant associations
between educational level and treatment condition and well-
being or quality of life (p>0.10).
Type D patients differed significantly from non-type D
patients on the omnibus test of the combined dependent
variables of aspects of quality of life (F [5,118]07.54, p<
0.001, η
200.24), while controlled for age, sex, education,
treatment and time since diagnosis. Patients with a type D
personality reported a lower psychological well-being than
non-type D patients. They showed more symptoms of anx-
iety and depression (F [1,122]017.37, p<0.001, η
200.13),
more negative affect (F [1,122]06.52, p00.01, η
200.05)
and less positive affect (F [1,122]09.10, p00.003, η
20
0.07) (Table 2). Type D patients also reported a lower
satisfaction with life than non-type D patients (F [1,122]0
25.44, p<0.001, η
200.17), but there was no significant
difference regarding the disability score (F [1,122]00.34,
p00.56, η
200.003).
When mindfulness was added to the model, the interac-
tion effect of type D by mindfulness was not significant in
the omnibus test (F [5,117]00.86, p00.51, η
200.01) or in
univariate analyses (all p>0.10). Mindfulness did show a
significant omnibus main effect on the combined dependent
variables of aspects of quality of life (F [5,117]02.71, p0
0.02, η
200.11). Univariate analyses showed that mindful-
ness was positively associated with positive affect (F
[1,121]09.14, p00.003; unstandardized β coefficient0
0.35, η
200.05) and satisfaction with life (F [1,121]05.58,
p00.02; unstandardizedβ00.24,η
200.05),butnoassociations
were found with the other variables.
Disease activity
Due to 42 missing values on the disease activity score, the
number of participants in the analyses on disease activity
was limited to 105. None of the covariates showed a signif-
icant association with disease activity (all p>0.10). Type D
patients did not differ from non-type D patients on the
combined dependent variables of disease activity in the
omnibus test (F [4, 100]00.81, p00.52, η
200.02). Also in
univariate tests on the separate DAS components and total
DAS-28,noeffects wereobtainedonerythrocytesedimentation,
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0.10). Also mindfulness and the type D by mindfulness inter-
action did not show significant effects: omnibus test (F [4,
93]00.38,p00.82,η
200.02and F [4, 93]01.45,p00.22,η
20
0.06, resp.) and univariate tests (p>0.10), except for erythro-
cytesedimentation(F[1,96]04.00,p00.048,η
200.04).Post-
hoc analyses revealed a nonsignificant tendency for mindful-
ness to be associated with lower erythrocyte sedimentation in
type D, but not in non-type D, individuals (r0−0.19, N032
type D, p>0.10versusr00.11, N078 non-type D, p>0.10).
Discussion
The main aim of the present study was to examine the
association of the distressed (type D) personality with
aspects of quality of life, including psychological well-
being, life satisfaction, and disability, as well as the disease
activity in RA patients. In multivariate analyses, in which
various potentially confounding variables were controlled,
type D patients reported lower positive mood, higher nega-
tive affect, more symptoms of anxiety and depression and
lower general satisfaction with life compared to non-type D
patients. No associations were found between type D per-
sonality and disability or disease activity scores. Also no
buffering effects by mindfulness were obtained. Although
the interaction effect between type D and mindfulness on
erythrocyte sedimentation was in the expected direction and
significant, the simple effects within type D and non-type D
groups were not. Because this may have been due to the
small subgroup sample sizes as a result of missing sedimen-
tation values, it may be fruitful for future studies to examine
this interaction effect in a larger sample. All in all, these
present results suggest that type D personality may be an
important psychological characteristic associated with psy-
chological well-being and life satisfaction, but not with
reported disability or objective disease indicators, in RA
patients.
The association between type D and lower psychological
well-being and aspects of quality of life has been found
earlier in several studies in cardiovascular patients [7, 18].
In these patients, a relation was also found between type D
personality and enhanced levels of pro-inflammatory cyto-
kines [20] and self-evaluated cardiac symptoms [15, 18].
The association between type D personality and disease
activity was not found in the present sample of RA patients.
First, one should note that in contrast to cardiovascular
patients, all RA patients use some form of anti-inflammatory
medication. Nevertheless, the lack of associations with
reported disability and objective disease indicators may be
Table 1 Characteristics of
patients with rheumatoid
arthritis with and without
distressed (type D) personality:
means (SD) or numbers (%)
Higher education—at least
midlevel vocational education
*p<0.01
Type D personality (N043) Non-type D personality (N098) to rχ
2
Age 54.9 (11.2) 58.4 (11.3) 1.70
Higher education 27 (62.8%) 59 (60.2%) 0.01
Female sex 25 (58.1%) 54 (55.1%) 0.00
Having a partner 32 (74.4%) 83 (84.7%) 0.75
TNF-alpha antagonist 7 (16.3%) 23 (23.5%) 0.69
Months since diagnosis 33.3 (72.3) 60.0 (111.7) 1.68
Mindfulness 35.0 (5.7) 38.4 (6.5) 2.94*
Table 2 Type D personality in
relation to psychological
well-being, quality of life and
disease activity: means (and
standard errors) from a
MANCOVA analysis
VAS visual analogue scale of
self-perceived disease severity,
DAS-28 disease activity score-28
*p<0.05; **p<0.01
aThe higher N concerns
self-report data, the lower N
concerns disease activity;
analyses were controlled for age,
gender, education level, time
since diagnosis and treatment
condition (methotrexate or TNFα
antagonist)
Type D (N031/43)
a Non-type D (N074/98)
a
Quality of life
Life satisfaction 20.94 (1.00)* 27.12 (0.68)**
Disability score 1.13 (0.10) 1.06 (0.07)
Psychological well-being
Positive affect 16.91 (1.22)* 21.38 (0.82)**
Negative affect 16.72 (1.43)** 12.26 (0.97)*
Anxiety and depression 5.56 (0.48)* 3.12 (0.33)**
Disease activity
Swollen joints 6.09 (0.94) 7.08 (0.61)
Tender joints 5.53 (0.86) 6.61 (0.56)
VAS 55.96 (4.81) 50.27 (3.13)
Erythrocyte sedimentation 27.88 (4.06) 28.43 (2.64)
Total DAS-28 4.77 (0.25) 4.70 (0.16)
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perform rather concrete and specific behaviours—in case of
the disability index—or mainly ratings by rheumatologists in
combination withphysiological parameters, bothof which are
less or not at all influenced by the subjective interpretation by
the patient as compared to the psychological variables used in
this study. It is known that type D personality is especially
associated with a gloomy view of life, as reflected by associ-
ations with all kinds of psychological symptoms and low
ratings of subjective satisfaction with quality of life [13, 18].
Why mindfulness did not buffer these associations is diffi-
cult to explain. One possibility is the fact that patients with a
type D personality scored significantly lower on mindfulness
compared to non-type Ds. Perhaps their lower mindfulness
scores prevented mindfulness to be able to buffer any effects
on psychological well-being. Another possibility is that the
instrument used to measure mindfulness in this study is of a
too global nature as mindfulness has been conceptualised as a
multidimensional construct [37]. Perhaps specific mindful-
ness skills, such as accepting one's thoughts and feelings
without judgement or having a nonreactive stance towards
these internal phenomena may be more directly associated
with various aspects of psychological well-being [37] and
with type D personality than a general mindfulness measure.
One may speculate ifan interventionaimed atthe enhance-
ment of specific mindfulness skills may be useful to increase
psychological well-being in type D patients, as such mindful-
ness interventions have been found to enhance psychological
well-being, satisfaction with life and coping with pain in
various patient populations [23-26, 28, 29]. Alternatively, it
has been suggested that more patient-tailored interventions
may be needed for type D patients to benefit from psycholog-
ical interventions [38]. Dependent on the specific problems
and needs of an individual patient, such an intervention may
applyacombinationofapproachesaimedatenhancingcoping
skills related to either the negative affectivity or social inhibi-
tion component of type D, or both. Such approaches may
include cognitive–behavioural therapy or mindfulness-based
cognitive therapy for the enhancement of mood and interper-
sonal therapy and assertiveness training for feeling more
comfortable in social situations, including the context of in-
teraction with health care providers [38]. Because such spe-
cific interventions for type D patients do not exist yet, despite
the fact that this personality type is associated with decreased
psychological well-being and satisfaction with life, the clini-
cian is advised to (a) routinely screen for type D personality
using the simple and brief 14-item DS-14 questionnaire [15]
and (b) offer these patients the possibility for a conversation
with a psychologist, who may assess in more depth the risk of
psychological problems in these patients, and possibly offer
them specific psychological treatment.
This study has a number of limitations which must be
considered when interpreting the results. First, the analyses
involved correlational data gathered at one time point, pre-
cluding any possible conclusions along causal lines. Sec-
ond, missing values in the disease activity score, especially
regarding the erythrocyte sedimentation, resulted in reduced
power of analyses on this outcome. In addition, it was not
possible to obtain erythrocyte scores at the same time point
as the other data, introducing a small time gap between the
assessment times, being 5.5 days on average, potentially
decreasing the effect size.
A merit of the study is the high response rate. Ninety-one
percent of patients asked to participate completed the ques-
tionnaires, resulting in adequate generalisability of the pres-
ent results to the RA population from which the participants
were drawn.
In conclusion, the present study showed associations of the
distressed (type D) personality with subjective indices of
aspects of quality of life, such as psychological well-being
and life satisfaction in RA patients, but not with disability or
objective indices of disease activity. Future research including
prospectivefollow-upassessmentsisneededtobeabletohelp
to draw conclusions along causal lines. If the present results
are confirmed and extended in future studies, interventions
may be designed to meet the needs of patients with a type D
personality, as outlined above.
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